JP2004529167A5 - - Google Patents

Download PDF

Info

Publication number
JP2004529167A5
JP2004529167A5 JP2002586950A JP2002586950A JP2004529167A5 JP 2004529167 A5 JP2004529167 A5 JP 2004529167A5 JP 2002586950 A JP2002586950 A JP 2002586950A JP 2002586950 A JP2002586950 A JP 2002586950A JP 2004529167 A5 JP2004529167 A5 JP 2004529167A5
Authority
JP
Japan
Prior art keywords
buffer
cyclodextrin
drug
histidine
prednisolone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002586950A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004529167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/013701 external-priority patent/WO2002089815A2/en
Publication of JP2004529167A publication Critical patent/JP2004529167A/ja
Publication of JP2004529167A5 publication Critical patent/JP2004529167A5/ja
Pending legal-status Critical Current

Links

JP2002586950A 2001-05-07 2002-04-29 殺菌および可溶化ステロイド組成物 Pending JP2004529167A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28933701P 2001-05-07 2001-05-07
PCT/US2002/013701 WO2002089815A2 (en) 2001-05-07 2002-04-29 Disinfecting and solubilizing steroid compositions

Publications (2)

Publication Number Publication Date
JP2004529167A JP2004529167A (ja) 2004-09-24
JP2004529167A5 true JP2004529167A5 (OSRAM) 2005-12-22

Family

ID=23111093

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002586950A Pending JP2004529167A (ja) 2001-05-07 2002-04-29 殺菌および可溶化ステロイド組成物

Country Status (9)

Country Link
US (1) US20020198174A1 (OSRAM)
EP (2) EP1385528B1 (OSRAM)
JP (1) JP2004529167A (OSRAM)
AT (1) ATE337010T1 (OSRAM)
AU (1) AU2002308544B2 (OSRAM)
CA (1) CA2446528A1 (OSRAM)
DE (1) DE60214157T2 (OSRAM)
ES (1) ES2269763T3 (OSRAM)
WO (1) WO2002089815A2 (OSRAM)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040152664A1 (en) * 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
WO2004069280A1 (en) * 2003-02-06 2004-08-19 Cipla Ltd Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
US20070224278A1 (en) 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050250737A1 (en) * 2003-11-12 2005-11-10 Allergan, Inc. Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
AU2004312096A1 (en) * 2003-12-31 2005-07-21 Cydex Pharmaceuticals, Inc. Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
AU2011235943B2 (en) * 2003-12-31 2014-06-26 Cydex Pharmaceuticals, Inc Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
CN100548271C (zh) 2004-01-20 2009-10-14 阿勒根公司 用于眼部的局部治疗、并优选包括有曲安奈德及透明质酸的组合物
ATE497787T1 (de) 2004-03-12 2011-02-15 Cipla Ltd Sterilisationsprozess für steroide
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
US8119154B2 (en) 2004-04-30 2012-02-21 Allergan, Inc. Sustained release intraocular implants and related methods
US8147865B2 (en) 2004-04-30 2012-04-03 Allergan, Inc. Steroid-containing sustained release intraocular implants and related methods
US6969706B1 (en) * 2004-05-12 2005-11-29 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
EP1761283A2 (en) * 2004-06-07 2007-03-14 California Institute Of Technology Biodegradable drug-polymer delivery system
US20060006361A1 (en) * 2004-07-08 2006-01-12 Joseph Callerame Clathrate of chlorine dioxide
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070178050A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an increased lung depositon
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197487A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an increased lung deposition
WO2007076448A2 (en) * 2005-12-23 2007-07-05 Alcon, Inc. Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (rtki) compounds to the eye
JP2009526851A (ja) * 2006-02-14 2009-07-23 ワイス ＥＲβ選択的リガンドの水性薬学的配合物
US20070238789A1 (en) * 2006-03-31 2007-10-11 Chin-Ming Chang Prednisolone acetate compositions
US8668676B2 (en) * 2006-06-19 2014-03-11 Allergan, Inc. Apparatus and methods for implanting particulate ocular implants
US20080097335A1 (en) 2006-08-04 2008-04-24 Allergan, Inc. Ocular implant delivery assemblies
JP2010531898A (ja) * 2007-06-28 2010-09-30 サイデックス・ファーマシューティカルズ・インコーポレイテッド 鼻および眼へのコルチコステロイド水溶液送達
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
US8054177B2 (en) * 2007-12-04 2011-11-08 Avaya Inc. Systems and methods for facilitating a first response mission at an incident scene using patient monitoring
US8545554B2 (en) 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
NZ627781A (en) 2012-01-23 2016-10-28 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
SG10201608148TA (en) 2012-08-21 2016-11-29 Sage Therapeutics Inc Methods Of Treating Epilepsy Or Status Epilepticus
JP2017524034A (ja) 2014-08-08 2017-08-24 フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． 受容体型チロシンキナーゼ阻害剤の安定で可溶な製剤およびその調製の方法
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
TW202400182A (zh) 2016-03-08 2024-01-01 美商賽吉醫療公司 神經活性類固醇，其組合物及用途
MA46997B1 (fr) 2016-11-29 2022-01-31 Oculis SA Préparation de complexes solides de cyclodextrine permettant une administration de substance pharmaceutique active ophtalmique
BR112021026564A2 (pt) 2019-07-01 2022-02-15 Oculis SA Método para estabilizar o ph de uma composição aquosa compreendendo um fármaco

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU185926B (en) * 1979-09-27 1985-04-28 Agostne Kahan Process for preparing water soluble derivatives of non-steroid antiinflammatory compositions and pharmaceutical compositins containing such derivatives
US4383992A (en) * 1982-02-08 1983-05-17 Lipari John M Water-soluble steroid compounds
DE3612538A1 (de) * 1986-04-14 1987-10-15 Dispersa Ag Stabilisierung von quecksilberhaltigen konservierungsmitteln in augentropfen
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5504113A (en) * 1994-03-02 1996-04-02 Allergan, Inc. Enhancement of benzalkonium chloride preservative activity in formulations containing an incompatible drug
US5891913A (en) * 1994-10-10 1999-04-06 Novartis Finance Corporation Ophthalmic and aural compositions containing diclofenac potassium
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
US5744154A (en) * 1995-09-06 1998-04-28 Laboratoire Chauvin S.A. Ready-to-use indomethacin-based eye lotion
JP3883739B2 (ja) * 1998-05-22 2007-02-21 株式会社メニコン コンタクトレンズ用殺菌液
JP2003517441A (ja) * 1998-09-25 2003-05-27 アルコン ラボラトリーズ， インコーポレイテッド 徐放性で快適な眼疾病用組成物および眼疾病の治療方法

Similar Documents

Publication Publication Date Title
JP2004529167A5 (OSRAM)
JP2008515556A5 (OSRAM)
JP2021506984A (ja) トリガーパルス薬物放出を有する胃内滞留型ｒａｆｔ形成システムを含む放出調節薬物粉末組成物
WO2004032862A3 (en) Cyclodextrin-based materials, compositions and uses related thereto
NO20051985L (no) Indazoler, benzotiazoler og benzoisotiazoler, samt fremstilling og anvendelser derav.
CA2526310A1 (en) Lipophilic fluid cleaning compositions capable of delivering scent
DE69918296D1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
JP2007302683A5 (OSRAM)
ATE327313T1 (de) Formulierungen enthaltend wasserlösliche granulate
DE602004031444D1 (de) Herstellung von monatin und monatinvorstufen
FR2856685B1 (fr) Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
WO2007067890A3 (en) Method of dust abatement
SE0102438D0 (sv) New compounds
JP2005530866A5 (OSRAM)
JP2003506416A5 (OSRAM)
WO2001092283A3 (en) Cobalamin compounds useful as cardiovascular agents and as imaging agents
WO2003097587A3 (en) Gelling agents
DE60022230D1 (de) Verfahren zur herstllung von clarithromycin polymorphen und polymorph iv
JP2008512527A5 (OSRAM)
WO2005001242A3 (en) Composition and method for diversion agents for acid stimulation of subterranean formations
WO2003006670A3 (en) 2-[5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
JP2006505678A5 (OSRAM)
JP2022009021A5 (OSRAM)
JP2004534739A5 (OSRAM)
MD1419G2 (ro) Complecşi de incluziune pe bază de SIN-1A şi ciclodextrină, compoziţii farmaceutice şi truse pe baza lor, procedeu de preparare a complecşilor de incluziune şi metodă de tratament